Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

263
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
263
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

620
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
620
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

169
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
169
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

389
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
389

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypergolic Copper Cluster-Based Covalent Organic Frameworks.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric Oncology.

medRxiv : the preprint server for health sciences·2026
Same author

Computed Tomography-Based Body Composition Assessment for Preoperative Cardiovascular Risk Prediction: A Prospective Cohort Study.

Anesthesiology·2026
Same author

Global reallocation of rainfed crops can boost production and reduce climate risk.

Nature food·2026
Same author

Making Waves: Bridging the scale gap in aquatic phosphorus cycling.

Water research·2026
Same author

Volatile food trade policy threatens biodiversity.

Science (New York, N.Y.)·2026
Same journal

Genotype Complexity Modulates Antimalarial Susceptibility in vitro.

Infection and drug resistance·2026
Same journal

Antimicrobial Resistance in Somalia: Surveillance Gaps, Stewardship Barriers, and One Health Priorities.

Infection and drug resistance·2026
Same journal

Development and in vitro Antifungal Evaluation of a Ternary Essential Oil-Based Oral Phytopharmaceutical Formulation Against <i>Candida albicans</i>.

Infection and drug resistance·2026
Same journal

Clinical Characteristics and Risk Factors of Carbapenem-Resistant <i>Escherichia coli</i> in Patients with Urinary Tract Infections: Development of a Predictive Nomogram.

Infection and drug resistance·2026
Same journal

Antifungal Susceptibility of Rare Yeasts Causing Vulvovaginal Candidiasis in the Acidic Vaginal Environment.

Infection and drug resistance·2026
Same journal

Noninvasive Prediction of Significant Hepatic Injury in Treatment-Naïve Children with Chronic HBV Infection.

Infection and drug resistance·2026
See all related articles

Related Experiment Video

Updated: Jun 26, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

419

Association Between ACE2 and Lung Diseases.

Cheng Su1, Cai Li2, Xinyi Hu3

  • 1School of Public Health, Huazhong University of Science and Technology, Wuhan, Hubei, People's Republic of China.

Infection and Drug Resistance
|May 13, 2024
PubMed
Summary
This summary is machine-generated.

Angiotensin-converting enzyme 2 (ACE2) is crucial for cardiovascular and pulmonary health. Understanding ACE2's role in lung diseases could lead to new diagnostic biomarkers.

Keywords:
ACE2ARDSCOPDLung Cancerlung diseases

More Related Videos

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.1K
Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

20.6K

Related Experiment Videos

Last Updated: Jun 26, 2025

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

419
Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.1K
Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling
05:47

Generation of Human 3D Lung Tissue Cultures 3D-LTCs for Disease Modeling

Published on: February 12, 2019

20.6K

Area of Science:

  • Biochemistry
  • Physiology
  • Pathology

Background:

  • Angiotensin-converting enzyme 2 (ACE2) regulates the Renin-Angiotensin System (RAS).
  • ACE2 serves as a functional receptor for Coronaviruses.
  • ACE2 influences cardiovascular regulation, impacting blood pressure and electrolyte balance.

Purpose of the Study:

  • To review and explore recent advancements in ACE2 research concerning pulmonary diseases.
  • To elucidate the pathological and physiological mechanisms of ACE2 in various lung conditions.

Main Methods:

  • Literature review of current ACE2 research.
  • Analysis of studies linking ACE2 to cardiovascular and pulmonary systems.
  • Exploration of ACE2's role in diseases like COPD, ARDS, and asthma.

Main Results:

  • ACE2 is implicated in cardiovascular regulation and is a key SARS-CoV receptor.
  • Evidence links ACE2 to diverse pulmonary diseases, including COPD, ARDS, and asthma.
  • The precise mechanisms of ACE2 in these lung diseases require further investigation.

Conclusions:

  • ACE2 plays a significant role in pulmonary diseases, beyond its known cardiovascular functions.
  • Further research into ACE2 mechanisms can identify potential biomarkers for early diagnosis and monitoring of lung conditions.